Bronchial carcinoid tumor treated with interferon and a new vaccine against NeuGcGM3 antigen expressed in malignant carcinoid cells

Cancer Biology and Therapy

Volumn 6, Issue 6, 2007, Pages 853-855

  Barroso Alvarez, M C ^a   Macías, Abraham A ^a   Saurez, Martínez G ^a   Fernández, Molina L E ^a   Lage, Dávila A ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

Bronchial carcinoids tumors; Interferon; NeuGcGM3 antigen; Therapeutic cancer vaccine; Treatment

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE; GANGLIOSIDE VACCINE; MONTANIDE ISA 51; PARACETAMOL; UNCLASSIFIED DRUG; DRUG DERIVATIVE; GANGLIOSIDE GM3; INTERFERON; N GLYCOLOYLNEURAMINYLLACTOSYLCERAMIDE; N-GLYCOLYLNEURAMINYLLACTOSYLCERAMIDE;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ANAMNESIS; ARTICLE; BRONCHUS CARCINOID; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CHILL; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DISEASE COURSE; FEMALE; FEVER; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INJECTION SITE PAIN; NEEDLE BIOPSY; PHYSICAL EXAMINATION; TREATMENT DURATION; TUMOR BIOPSY; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION; BRONCHUS TUMOR; CARCINOID; DISEASE FREE SURVIVAL; IMMUNOLOGY; METHODOLOGY; RECURRENT DISEASE; REMISSION;

ADOLESCENT; BRONCHIAL NEOPLASMS; CANCER VACCINES; CARCINOID TUMOR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; G(M3) GANGLIOSIDE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-ALPHA; INTERFERONS; RECURRENCE; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 42449159312     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.6.4186     Document Type: Article

References (18)

1. Hage R, Brutel de la Riviere A, Seldenrijk CA, Van den Bosch JMM. Update in pulmonary carcinoid tumor: A review article. Ann Surgical Oncol 2003; 10:697-704.
2. Lubarch O. Primären Kreps des Ileum, Nebst Bemerkungen Über das Gleichzeitige Vorkommen, von Kreps und Tuberkolose. Virchows Arch 1888; 111:280-317.
3. Fröhlich F. Die "Helle Zelle"der Bronchialschleimhaut und ihrd Beziehungen zum Problem der Chemoreceptoren. Frankfurter Z Pathol 1949; 60:517.
4. Travis WD, Rush W, Flieder DB. Survival analysis of two hundred pulmonary neuroendocrine tumor with clarification of criteria for atypical carcinoid and it separation from typical carcinoid. Ann Surgical Path 1998; 22:934-44.
5. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumor of the lung. J Thorax Cardiovas Sur 1972; 64:413-21.
6. Gugger M, Burckhardt E, Kappeler A, Hirsiger H, Laissue JA, Mazzucchelli L. Cuantitave expression of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. J Pathology 2002; 196:408-15.
7. Ullmann R, Pitzman S, Klemen H, Fraire AE, Hasleton P, Popper HH. Deposition of pulmonary carcinoid within the spectrum of neuroendocrine tumor of the lung and other tissues. Genes Chromos Cancer 2002; 34:78-85.
8. Thomas CH, Tazelaar HD, Jett JR. Typical and atypical pulmonary carcinoids. Chest 2001; 119:1143-50.
9. Kaltsar GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced NET. Endocr Rev June, 2004; 25:3458-511.
10. Marquina G, Waki H, Fernandez LE, Kon K, Carr A, Valiente O. Gangliosides expressed in human breast cancer. Cancer Res 1996; 56:5165-71.
11. Carr A, Mullet A, Mazorra Z, Vázquez AM, Alfonso M. A mouse IgG1 monoclonal antibody specific for N-Nglycolyl GM3 ganglioside recognized breast cancer and melanoma tumors. Hybridoma 2000; 19:241.
12. Estévez F, Carr A, Solorzano L, Valiente O, Mesa C, Barroso O, Sierra GV, Fernández LE. Enhancement of the immune response to poorly immunogenic ganglioside after incorporation into very small size proteolyposome (VSSP). Vaccine 1999; 18:190-7.
13. Carr A, Rodríguez E, Arango MC, Camacho R, Osorio M, Gabri M, Carrillo G, Valdés Z, Bebelagua Y, Pérez R, Fernández LE. Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine. J Clin Oncol 2003; 21:1015-1021.
14. th EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics". 2005.
15. NCI, PDQ: Unusual cancer of childhood treatment. Bronchial Tumors. (Available in: http://www.cancer.gov).
16. Oberg K. Chemotherapy and biotherapy in the treatment of GINET. Ann Oncol 1999; 12:S111-4.
17. Oberg K. Interferon in the management of NET: A review. Digestion 62:92-97.
18. Oberg K. State of the art and future directions in the management of NET. Q J Nucl Med 2000; 44:3-12.